Medical Weight Loss for Bethel, Alaska Residents

Bethel, Alaska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Bethel through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Bethel, Alaska by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Bethel Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Bethel is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Alaska trust us to guide a serious decision about their health.

If you are searching for medical weight loss in Bethel, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

Think of our Costa Mesa clinic as your weight-loss provider even though you live in Bethel, because telehealth delivers the same physician-led program to Alaska without asking you to leave home. We care for patients throughout Bethel and the Yukon-Kuskokwim Delta region of western Alaska. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Bethel patient.

Telehealth lets you skip the commute entirely, so the time you would have spent driving across Bethel goes straight into starting your program. If you and Dr. Sharma decide tirzepatide fits your goals, Bethel patients can begin from $233 per month, billed apart from your initial $119 visit. Even in a state as spread out as Alaska, New Hope Weight Loss reaches patients by secure telehealth from our Costa Mesa, California clinic, so distance never stands between you and physician-supervised care.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Bethel patients.

How Telehealth Works for Bethel

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Bethel address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Bethel

I live in Bethel. Is the nearest New Hope Weight Loss office close by?

The nearest office is in Costa Mesa, California, which is our only physical site. That said, you do not have to be near it. We treat Bethel, Alaska patients by telehealth, and a video consult with Dr. Anjmun Sharma confirms whether you are a candidate for compounded semaglutide or tirzepatide.

Will I ever need to show up in person if I am in Bethel?

No in-person visits are needed for Bethel residents. The entire program is telehealth, from your first consult to refills and check-ins. When you qualify, your medication ships to Bethel in cold-pack packaging designed to maintain the proper temperature throughout shipping.

What are the prices for Bethel residents?

A physician review costs $119. Compounded semaglutide is priced from $166 per month or $499 for a 90-day course, and tirzepatide from $233 per month. Medication is charged on its own. Payment through HSA, FSA, Klarna, or Affirm is accepted, and we never add a distance surcharge for Bethel.

What areas of Bethel do you serve?

We serve patients from across Bethel by telehealth, including Bethel and the Yukon-Kuskokwim Delta region of western Alaska.

How does telehealth treatment work for Bethel patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Bethel address. Follow-ups also happen by video.

Bethel Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bethel, Alaska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.